文献速递角膜与眼表疾病

角膜疾病治疗证据的可靠性:系统综述汇总

Reliability of the Evidence Addressing Treatment of Corneal Diseases: A Summary of Systematic Reviews.
PubMed 文献 · JAMA Ophthalmol · 2019-01-01

该研究从Cochrane Eyes and Vision US Satellite数据库检索1997至2017年关于15种角膜疾病干预措施的系统综述,按5项标准将98篇系统综述分为可靠与不可靠,发现33篇(34%)不可靠,最常见原因为未全面检索文献、未评估偏倚风险及未采用合适的定量合成方法。

要点

  • 98篇角膜疾病干预系统综述中33篇(34%)被分类为不可靠。
  • 不可靠最常见原因为未全面检索文献(22/33,67%)和未评估偏倚风险(13/33,39%)。
  • 65篇可靠系统综述中42篇涉及2018年美国眼科学会PPP相关角膜疾病,其中33篇被PPP引用。

核心结论

  • 每3篇角膜疾病干预系统综述中约有1篇不可靠,因而未被用于指导PPP推荐。

研究设计与样本

  • 研究为对已发表系统综述的汇总分析,数据来源为Cochrane Eyes and Vision US Satellite数据库,检索1997至2017年(中位年份2014)的系统综述。
  • 共纳入98篇系统综述,涉及15种角膜疾病的干预措施。

主要发现

  • 98篇系统综述中33篇(34%)被分类为不可靠。
  • 不可靠的最常见原因为未全面检索文献(22/33,67%)、未评估纳入研究的偏倚风险(13/33,39%)以及未采用合适的定量合成方法(12/17篇进行定量合成的系统综述,71%)。
  • 65篇(66%)系统综述被分类为可靠,其中42篇(65%)涉及与2018年美国眼科学会PPP相关的角膜疾病,这42篇中33篇(79%)被2018年PPP引用。

关键数值与推荐

  • 系统综述需同时满足5项标准才被分类为可靠:明确纳入研究的 eligibility criteria、进行全面文献检索、评估纳入研究的偏倚风险、采用合适的定量合成方法(仅在进行Meta分析时评估)、结论有系统综述结果支持。
  • 至少1项标准未满足即被分类为不可靠。

临床怎么用

  • 患者诊疗应以临床实践指南为依据,而指南应以可靠系统综述的证据为依据。
  • 不可靠的系统综述未被用于指导PPP推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Patient care should be informed by clinical practice guidelines, which in turn should be informed by evidence from reliable systematic reviews. The American Academy of Ophthalmology is updating its Preferred Practice Patterns (PPPs) for the management of the following 6 corneal diseases: bacterial keratitis, blepharitis, conjunctivitis, corneal ectasia, corneal edema and opacification, and dry eye syndrome. OBJECTIVE: To summarize the reliability of the existing systematic reviews addressing interventions for corneal diseases. DATA SOURCE: The Cochrane Eyes and Vision US Satellite database. STUDY SELECTION: In this study of published systematic reviews from 1997 to 2017 (median, 2014), the Cochrane Eyes and Vision US Satellite database was searched for systematic reviews evaluating interventions for the management of any corneal disease, combining eyes and vision keywords and controlled vocabulary terms with a validated search filter. DATA EXTRACTION AND SYNTHESIS: The study classified systematic reviews as reliable when each of the following 5 criteria were met: the systematic review specified eligibility criteria for inclusion of studies, conducted a comprehensive literature search for studies, assessed risk of bias of the individual included studies, used appropriate methods for quantitative syntheses (meta-analysis) (only assessed if meta-analysis was performed), and had conclusions that were supported by the results of the systematic review. They were classified as unreliable if at least 1 criterion was not met. MAIN OUTCOMES AND MEASURES: The proportion of systematic reviews that were reliable and the reasons for unreliability. RESULTS: This study identified 98 systematic reviews that addressed interventions for 15 corneal diseases. Thirty-three of 98 systematic reviews (34%) were classified as unreliable. The most frequent reasons for unreliability were that the systematic review did not conduct a comprehensive literature search for studies (22 of 33 [67%]), did not assess risk of bias of the individual included studies (13 of 33 [39%]), and did not use appropriate methods for quantitative syntheses (meta-analysis) (12 of 17 systematic reviews that conducted a quantitative synthesis [71%]). Sixty-five of 98 systematic reviews (66%) were classified as reliable. Forty-two of the 65 reliable systematic reviews (65%) addressed corneal diseases relevant to the 2018 American Academy of Ophthalmology PPPs; 33 of these 42 systematic reviews (79%) are cited in the 2018 PPPs. CONCLUSIONS AND RELEVANCE: One in 3 systematic reviews addressing interventions for corneal diseases are unreliable and thus were not used to inform PPP recommendations. Careful adherence by systematic reviewers and journal editors to well-established best practices regarding systematic review conduct and reporting might help make future systematic reviews in eyes and vision more reliable.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Saldanha IJ, Lindsley KB, Lum F, et al. Reliability of the Evidence Addressing Treatment of Corneal Diseases: A Summary of Systematic Reviews. JAMA Ophthalmol. 2019. PMID: 31070698. doi:10.1001/jamaophthalmol.2019.1063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。